Immunitybio shares owned by Goldman Sachs Group
Quarter-by-quarter ownership of Immunitybio (IBRX) shares owned by Goldman Sachs Group
from 13F filings
Historical chart of Goldman Sachs Group investment in Immunitybio
Tip: Access up to 7 years of quarterly data
All positions including Immunitybio held by Goldman Sachs Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Immunitybio by Goldman Sachs Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-03-31 | $6.5M | 1.2M | 5.37 |
| 2023-12-31 | $6.5M | 1.3M | 5.02 |
| 2023-09-30 | $723k | 428k | 1.69 |
| 2023-06-30 | $759k | 273k | 2.78 |
| 2023-03-31 | $644k | 354k | 1.82 |
| 2022-12-31 | $5.8M | 1.2M | 5.07 |
| 2022-06-30 | $2.1M | 571k | 3.72 |
| 2022-03-31 | $2.3M | 408k | 5.61 |
| 2021-12-31 | $1.6M | 262k | 6.08 |
| 2021-09-30 | $2.2M | 226k | 9.74 |
| 2021-03-31 | $1.9M | 81k | 23.74 |